TOTakafumi Oga

Takafumi Oga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takafumi Oga has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes

    by Takafumi Oga, Yoshihiro Yamashita, Manabu Soda, Shinya Kojima, Toshihide Ueno, Masahito Kawazu, Nobuaki Suzuki, Hiroaki Nagano, Shoichi Hazama, Masashi Izumiya, et al.

    Every year, approximately 1.2 million cases of colorectal carcinoma (CRC) are newly diagnosed worldwide. Although metastases to distant organs are often fatal complications of CRC, little information is known as to how such metastatic lesions are formed. To reveal the genetic profiles for CRC metastasis, we conducted whole‐exome RNA sequencing on CRC tumors with liver metastasis (LM) (group A, n = 12) and clinical stage‐matched larger tumors without LM (group B, n = 16). While the somatic mutation profiles were similar among the primary tumors and LM lesions in group A and the tumors in group B, the A‐to‐C nucleotide change in the context of “AAG” was only enriched in the LM regions in group A, suggesting the presence of a DNA damage process specific to metastasis. Genes already known to be associated with CRC were mutated in all groups at a similar frequency, but we detected somatic nonsynonymous mutations in a total of 707 genes in the LM regions, but not in the tumors without LM. Signaling pathways linked to such “LM‐associated” genes were overrepresented for extracellular matrix‐receptor interaction or focal adhesion. Further, fusions of the ADAP1 (ArfGAP with dual PH domain 1) were newly identified in our cohort (3 out of 28 patients), which activated ARF6, an ADAP1‐substrate. Infrequently, mutated genes may play an important role in metastasis formation of CRC. Additionally, recurrent ADAP1 fusion genes were unexpectedly discovered. As these fusions activate small GTPase, further experiments are warranted to examine their contribution to CRC carcinogenesis.


  • Open Access

    Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial

    by Akihiro Nomura, Tomoyuki Tanigawa, Tomoyasu Muto, Takafumi Oga, Yasushi Fukushima, Arihiro Kiyosue, Masaki Miyazaki, Eisuke Hida, Kohta Satake

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Tobacco is a major public health concern. A 12-week standard smoking cessation program is available in Japan; however, its required face-to-face clinic visits has been one of the key obstacles to completing the program, leading to a low smoking cessation success rate. Telemedicine using an internet-based video counseling instead of regular clinic visits could address the obstacles. Objective: This study aimed to evaluate the efficacy and feasibility of an internet-based remote smoking cessation support program compared with the standard face-to-face clinical visit program among patients with nicotine dependence. Methods: This study was a randomized, controlled, open-label, multi-center, non-inferiority trial. We recruited nicotine-dependent adults from March to June 2018. Participants randomized to the telemedicine arm underwent an internet-based video counseling, whereas control participants underwent standard face-to-face clinical visits at each time point on the smoking cessation program. Both arms received a CureApp Smoking Cessation smartphone application with a mobile exhaled carbon monoxide checker. The primary outcome was a continuous abstinence rate (CAR) at weeks 9–12. We conducted all analyses by full analysis set. Results: We randomized 115 participants with nicotine dependence: 58 were allocated to the telemedicine (internet-based video counseling) arm and 57, to the control (standard face-to-face clinical visit) arm. We analyzed all 115 participants for the primary outcome. Both telemedicine and control groups had similar CARs at weeks 9–12 (telemedicine vs. control, 81.0% vs. 78.9%; absolute difference, 2.1%; 95% confidence interval, -12.8 to 17.0); the lower limit of the difference between groups (-12.8%) was greater than a pre-specified limit (-15%). Conclusions: The application of telemedicine using internet-based video counseling as a smoking cessation program had a similar CAR at weeks 9–12 as the standard face-to-face clinical visit program. The efficacy of the telemedicine-based smoking cessation program was non-inferior to that of the standard visit-based smoking cessation program. Clinical Trial: This trial was registered at the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN ID: UMIN000031620).


  • Open Access

    Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial (Preprint)

    by Akihiro Nomura, Tomoyuki Tanigawa, Tomoyasu Muto, Takafumi Oga, Yasushi Fukushima, Arihiro Kiyosue, Masaki Miyazaki, Eisuke Hida, Kohta Satake

    BACKGROUND Tobacco is a major public health concern. A 12-week standard smoking cessation program is available in Japan; however, it requires face-to-face clinic visits, which has been one of the key obstacles to completing the program, leading to a low smoking cessation success rate. Telemedicine using internet-based video counseling instead of regular clinic visits could address this obstacle. OBJECTIVE This study aimed to evaluate the efficacy and feasibility of an internet-based remote smoking cessation support program compared with the standard face-to-face clinical visit program among patients with nicotine dependence. METHODS This study was a randomized, controlled, open-label, multicenter, noninferiority trial. We recruited nicotine-dependent adults from March to June 2018. Participants randomized to the telemedicine arm received internet-based video counseling, whereas control participants received standard face-to-face clinic visits at each time point in the smoking cessation program. Both arms received a CureApp Smoking Cessation smartphone app with a mobile exhaled carbon monoxide checker. The primary outcome was a continuous abstinence rate (CAR) from weeks 9 to 12. Full analysis set was used for data analysis. RESULTS We randomized 115 participants with nicotine dependence: 58 were allocated to the telemedicine (internet-based video counseling) arm and 57, to the control (standard face-to-face clinical visit) arm. We analyzed all 115 participants for the primary outcome. Both telemedicine and control groups had similar CARs from weeks 9 to 12 (81.0% vs 78.9%; absolute difference, 2.1%; 95% CI –12.8 to 17.0), and the lower limit of the difference between groups (–12.8%) was greater than the prespecified limit (–15%). CONCLUSIONS The application of telemedicine using internet-based video counseling as a smoking cessation program had a similar CAR from weeks 9 to 12 as that of the standard face-to-face clinical visit program. The efficacy of the telemedicine-based smoking cessation program was not inferior to that of the standard visit–based smoking cessation program. CLINICALTRIAL University Hospital Medical Information Network Clinical Trials Registry: UMIN000031620; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035975.